Clinical trial for Psoriasis
Official title A Study to Evaluate the Impact of a Magnolia Officinalis Dietary Supplement on Immune Biomarkers in Subjects With Psoriasis
ClinicalTrials.gov ID: NCT07471048
What this study is testing
- What it's testing
- The study aims to find out if taking a specific plant-based supplement affects levels of proteins linked to immune activity in people with psoriasis.
- Who it's for
- The study is looking for adults who have psoriasis.
- What's involved
- Participants will take a daily supplement or a look-alike placebo for three months. They will fill out online questionnaires about their symptoms and use at-home kits to collect blood samples at the start, one month, and three months.
- Time commitment
- The study lasts three months and requires participants to collect blood samples and complete questionnaires at three specific times.
You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Male of female, aged 18 years or older at time of consent.
- Diagnosis of stable psoriasis affecting for at least 6 months confirmed by a dermatologist.
- Patients with psoriasis-associated comorbidities including psoriatic arthritis are permitted, as long as those comorbidities are not severe enough to...
You likely can't join if
- Able to read and understand English.
- Able to read, understand, and provide informed consent.
- Able to use a personal smartphone device and download Chloe by People Science.
- Able to receive shipment of the product at an address within the United States.
- Do not have a personal smartphone, internet access, or unwilling to download Chloe.
- Prior treatment with any systemic non-biologic immunosuppressive agents (e.g., methotrexate, cyclosporine, azathioprine) within 8 weeks prior to...
See the full eligibility criteria
- Male of female, aged 18 years or older at time of consent.
- Diagnosis of stable psoriasis affecting for at least 6 months confirmed by a dermatologist.
- Patients with psoriasis-associated comorbidities including psoriatic arthritis are permitted, as long as those comorbidities are not severe enough to require treatment with systemic therapies as defined in the
- Able to read and understand English.
- Able to read, understand, and provide informed consent.
- Able to use a personal smartphone device and download Chloe by People Science.
- Able to receive shipment of the product at an address within the United States.
- Do not have a personal smartphone, internet access, or unwilling to download Chloe.
- Prior treatment with any systemic non-biologic immunosuppressive agents (e.g., methotrexate, cyclosporine, azathioprine) within 8 weeks prior to randomization.
- Prior treatment with any systemic biologic therapies (e.g., guselkumab, risankizumab, ustekinumab, secukinumab, brodalumab, infliximab, adalimumab, golimumab, etanercept) within 6 months prior to randomization
- Prior treatment with any other systemic investigational drugs within 6 months prior to randomization.
- Currently pregnant, planning to become pregnant in the next 3 months, or breastfeeding
- Any underlying medical conditions or comorbidities that may confound the assessment of digestive symptoms or the evaluation of the study outcomes.
- Have a significant illness, disease or condition which, in the opinion of the principal investigator, may impact their ability to participate in the study or impact the study outcomes.
- Known hypersensitivity or previous allergic reaction to magnolia, rice or hypromellose.
- Are unlikely for any reason to be able to comply with the trial or considered unsuited for participation in the study by the Principal Investigator.
The study team makes the final eligibility decision.
Where it is enrolling
- Englewood, New Jersey, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Englewood, New Jersey, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.